Single answer
Is Alumis Inc Common Stock (ALMS) a buy or sell?
4starter turns market data into one clear verdict you can act on.
Create a free account to save tickers and track your signals.
Log in to turn on watchlist alerts.
Decision snapshot
Everything you need to act fast, in one glance.
What is the conclusion?
Right now our advanced algorithms say:
$1 invested is now $1.53 or 52.58%
(In 7 weeks 1 day 3 hours 48 minutes and 22 seconds .)
Do analysts agree?
We compare consensus targets with today's price.
Consensus target for Alumis Inc Common Stock is $37.50, which is $8.60 (29.75%) above the current price today's price.
Low target: $32.00 | High target: $50.00
Latest analyst updates
Recent rating and price target changes for this stock.
Company snapshot
A quick overview of the business and its public profile.
Alumis Inc a clinical stage biopharmaceutical company focuses on the development and commercialization of medicines for autoimmune disorders It develops ESK001 an allosteric tyrosine kinase 2 TYK2 inhibitor for the treatment of plaque psoriasis systemic lupus erythematosus and noninfectious uveitis and A005 a central nervous systempenetrant allosteric TYK2 inhibitor for neuroinflammatory and neurodegenerative diseases The company was formerly known as Esker Therapeutics Inc and changed its name to Alumis Inc in January 2022 The company was incorporated in 2021 and is headquartered in South San Francisco California
Website: https://www.alumis.com
Rates and inflation backdrop
US inflation for January 2026 was 0.17%. Over the last 12 months, inflation is 2.83%. The 10-year yield is 4.04 and is down -0.110 over the last 30 days.
Inflation sensitivity
Debt ratio: 0.08. Cash flow to debt ratio: -9.85. Net profit margin: -1,108.24%. Inflation risk score: medium (0.70/1).
Dividend history check
We cannot find any recorded dividends paid in our systems.
Trading liquidity
Yes, the average daily trading liquidity for Alumis Inc Common Stock is $34.9M. You should therefore be able to get in and out of your positions relatively fast.
10-year return check
We cannot find data for Alumis Inc Common Stock 10 years ago, but if you had invested on 2024-06-28 when the price was $13.30, you would have made a profit of $16.09 per share or 120.98%.
Why this answer
We combine price momentum, volatility, and trend signals to simplify the decision to one word.
Signal engine scans price, trend, and momentum indicators.
Targets and sentiment are checked against the live quote.
We keep the output simple: buy, sell, or hold.
Analyst consensus
How Wall Street targets compare to today's price.